Target intelligence / Profile preview

La-related protein 7 (LARP7)

Target
LARP7
Molecular classification
RNA-binding protein, Transcriptional regulator, Ribonucleoprotein complex component, RNA chaperone, Other
01

Overview

La-related protein 7 (LARP7) is an essential RNA-binding protein that acts as a transcriptional regulator primarily by stabilizing the 7SK small nuclear RNA (7SK snRNA) within the 7SK ribonucleoprotein (RNP) complex[1][3][4][5]. LARP7 directly binds the 3′ oligo-uridine tail and stem-loop 4 (SL4) of 7SK RNA through its N-terminal La module and C-terminal atypical RNA recognition motif domains, forming a stable core RNP[1][3][4]. This complex sequesters positive transcription elongation factor b (P-TEFb), thereby tightly regulating the transition of RNA Polymerase II into productive elongation during gene transcription[1][5]. Loss or mutation of LARP7 disrupts 7SK snRNP stability, leading to abnormal P-TEFb activity, deregulated transcription, and has been linked to human diseases such as various cancers and primordial dwarfism (Alazami syndrome)[1][4][5]. In some organisms, LARP7 family proteins also chaperone non-coding RNAs involved in telomerase assembly and telomere maintenance[2][6]. There are currently no approved drugs directly targeting LARP7, but its fundamental role in gene expression raises caution for druggability due to possible widespread effects on cell viability if perturbed[1][5].

Other names
La ribonucleoprotein 7HDCMA18PhLARP7PIP7SDKFZP564K112La ribonucleoprotein domain family member 7P-TEFb-interaction protein for 7SK stabilityALAZS
02

Mechanism of action

Not applicable; currently, there are no drugs known to target LARP7 directly

03

Biological functions

Regulation of transcription elongationAssembly and stabilization of ribonucleoprotein complexesRNA processing and protectionTelomerase biogenesis (in some species)
04

Disease associations

Cancer (including gastric, breast, and cervical cancer)Primordial dwarfism (e.g., Alazami syndrome)Other (growth retardation and telomere maintenance disorders)
05

Safety considerations

Potential wide-ranging effects on transcriptional homeostasis and cell viability if targeted, given fundamental role in RNA metabolism and global gene expression
06

Interacting drugs

None known
07

Biomarkers

Loss-of-function mutations or reduced protein levels of LARP7 (for Alazami syndrome, certain cancers)

Beyond the preview

Go deeper on La-related protein 7 (LARP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on La-related protein 7 (LARP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call